Published on in Vol 5, No 3 (2016): Jul-Sept

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial)

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial)

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial)

Cari Stek 1, 2, 3, MD;  Charlotte Schutz 2, 3, MBChB, DipHIVMan(SA), MPH;  Lisette Blumenthal 2, 3, MBChB, DipHIVMan(SA);  Friedrich Thienemann 2, 3, MD;  Jozefien Buyze 1, PhD;  Christiana Nöstlinger 4, PhD;  Raffaella Ravinetto 1, PharmD, PhD;  Edwin Wouters 5, PhD;  Robert Colebunders 1, MD, PhD;  Gary Maartens 2, MMed;  Robert J Wilkinson 2, 3, 6, 7, MA, BMBCh, DTM&H, PhD;  Lutgarde Lynen 1, MD, PhD;  Graeme Meintjes 2, 3, MBChB, FCP(SA), FRCP(UK), DipHIVMan(SA), MPH, PhD

1 Institute of Tropical Medicine, Department of Clinical Sciences , Antwerp , BE

2 Department of Medicine , University of Cape Town, Cape Town , ZA

3 Institute of Infectious Disease and Molecular Medicine, Clinical Infectious Diseases Research Initiative, University of Cape Town, Cape Town , ZA

4 Department of Public Health, Institute of Tropical Medicine , Antwerp , BE

5 Department of Sociology, Centre for Longitudinal and Life Course Studies, University of Antwerp, Antwerp , BE

6 Department of Medicine , Imperial College London, London , GB

7 The Francis Crick Institute, Mill Hill Laboratory , London , GB

Corresponding Author:

  • Cari Stek, MD
  • Institute of Infectious Disease and Molecular Medicine
  • Clinical Infectious Diseases Research Initiative
  • University of Cape Town
  • Anzio Road
  • Observatory
  • Cape Town
  • ZA
  • Phone: 27 21 406 6389
  • Email: cari_stek@hotmail.com